Drug Profile
Research programme: influenza A H1N1 vaccine - Etubics
Alternative Names: H1N1 influenza vaccine - EtubicsLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Etubics Corporation
- Class Influenza A virus H1N1 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Influenza A virus H1N1 subtype
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Influenza-A-virus-H1N1-subtype(Prevention) in USA (Parenteral, Injection)
- 29 Jul 2010 Preclinical trials in Influenza-A virus H1N1 subtype in USA (Parenteral)